EXTROVIS AG

Overview

EXTROVIS AG is an active pharmaceutical ingredient (API) supplier with 8 active FDA Type II Drug Master Files, covering AVIBACTAM SODIUM STERILE; CALCIUM GLUCONATE; DAPSONE; DIBASIC POTASSIUM PHOSPHATE; ELTROMBOPAG OLAMINE; MONOBASIC POTASSIUM PHOSPHATE.

API / Drug Master Files

EXTROVIS AG holds 8 active (9 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• AVIBACTAM SODIUM STERILEActive2025-12-30
• TRABECTEDINActive2024-02-09
• MONOBASIC POTASSIUM PHOSPHATEActive2023-08-08
• DIBASIC POTASSIUM PHOSPHATEActive2023-08-04
• CALCIUM GLUCONATEActive2023-07-05
• ELTROMBOPAG OLAMINEActive2023-03-29
• TOLVAPTANActive2020-01-22
• DAPSONEActive2019-03-09
• SUGAMMADEX SODIUMInactive2020-12-22

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to EXTROVIS AG in our records. PharmaTek screens the full directory against live FDA enforcement data.